J. Vardiman, J. Thiele, and D. Arber, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood, vol.114, issue.5, pp.937-951, 2009.
DOI : 10.1182/blood-2009-03-209262

J. Feuillard, M. Jacob, and F. Valensi, Clinical and biologic features of CD4+CD56+ malignancies, Blood, vol.99, issue.5, pp.1556-1563, 2002.
DOI : 10.1182/blood.V99.5.1556

A. Jegalian, N. Buxbaum, and F. Facchetti, Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications, Haematologica, vol.95, issue.11, pp.1873-1879
DOI : 10.3324/haematol.2010.026179

P. Reimer, R. T. Kraemer, and D. , What is CD4+CD56+ malignancy and how should it be treated?, Bone Marrow Transplantation, vol.32, issue.7, pp.637-646, 2003.
DOI : 10.1038/sj.bmt.1704215

T. Marafioti, J. Paterson, and E. Ballabio, Novel markers of normal and neoplastic human plasmacytoid dendritic cells, Blood, vol.111, issue.7, pp.3778-3792, 2008.
DOI : 10.1182/blood-2007-10-117531

R. Dijkman, R. Van-doorn, K. Szuhai, R. Willemze, M. Vermeer et al., Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities, Blood, vol.109, issue.4, pp.1720-1727, 2007.
DOI : 10.1182/blood-2006-04-018143

F. Jardin, M. Callanan, and D. Penther, Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease, Leukemia, vol.5, issue.4, pp.698-707, 2009.
DOI : 10.1073/pnas.86.22.8867

F. Garnache-ottou, J. Feuillard, and P. Saas, Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?, British Journal of Haematology, vol.20, issue.4, pp.539-548, 2007.
DOI : 10.1182/blood-2004-09-3502
URL : https://hal.archives-ouvertes.fr/hal-00451209

C. Cota, E. Vale, and I. Viana, Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm???Morphologic and Phenotypic Variability in a Series of 33 Patients, The American Journal of Surgical Pathology, vol.34, issue.1, pp.75-87
DOI : 10.1097/PAS.0b013e3181c5e26b

F. Garnache-ottou, J. Feuillard, and C. Ferrand, Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia, British Journal of Haematology, vol.75, issue.5, pp.624-636, 2009.
DOI : 10.1111/j.1365-2141.2009.07679.x
URL : https://hal.archives-ouvertes.fr/hal-00451257

F. Garnache-ottou, L. Chaperot, and S. Biichle, Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis, Blood. Epub Am J Clin Pathol, vol.105122, issue.12, pp.1256-1264307, 1223.

Y. Pekarsky, C. Hallas, and C. Croce, The role of TCL1 in human T-cell leukemia, Oncogene, vol.20, issue.40
DOI : 10.1038/sj.onc.1204596

M. Herling, M. Teitell, R. Shen, L. Medeiros, D. Jones et al., TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin Regulation of TCL1 expression in Band T-cell lymphomas and reactive lymphoid tissues, Blood. Cancer Res, vol.10160, pp.5007-50092095, 2000.

X. Ju, C. Hacker, and B. Scherer, Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation, Gene, vol.331, pp.159-164, 2004.
DOI : 10.1016/j.gene.2004.02.018

B. Cisse, M. Caton, and M. Lehner, Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development Opn: key regulator of pDC interferon production, Cell. Nat Immunol, vol.1357, issue.18, pp.37-48441, 2006.

M. Bene, G. Castoldi, and W. Knapp, Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL), Leukemia, vol.9, pp.1783-1786, 1995.

R. Garand and N. Robillard, Immunophenotypic characterization of acute leukemias and chronic lymphoproliferative disorders: practical recommendations and classifications, Hematology and Cell Therapy, vol.38, issue.6, pp.471-486, 1996.
DOI : 10.1007/s00282-996-0471-4

W. Cao, L. Bover, L. Martin-martin, J. Almeida, P. Hernandez-campo et al., Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells, Immunological Reviews, vol.180, issue.1, pp.163-176, 2009.
DOI : 10.1111/j.0105-2896.2009.00867.x

W. Cao, D. Rosen, and T. Ito, Plasmacytoid dendritic cell???specific receptor ILT7???Fc??RI?? inhibits Toll-like receptor???induced interferon production, The Journal of Experimental Medicine, vol.203, issue.6, pp.1399-1405, 2006.
DOI : 10.1038/nbt836

Y. Pekarsky, U. Santanam, and A. Cimmino, Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by miR-29 and miR-181, Cancer Research, vol.66, issue.24, pp.11590-11593, 2006.
DOI : 10.1158/0008-5472.CAN-06-3613